Sung, Pamela J. http://orcid.org/0000-0002-5828-5622
Selvam, Murugan
Riedel, Simone S.
Xie, Hongbo M.
Bryant, Katie
Manning, Bryan
Wertheim, Gerald B.
Kulej, Katarzyna
Pham, Lucie
Bowman, Robert L.
Peresie, Jennifer
Nemeth, Michael J.
Levine, Ross L. http://orcid.org/0000-0002-7884-1905
Garcia, Benjamin A.
Meyer, Sara E.
Sidoli, Simone
Bernt, Kathrin M. http://orcid.org/0000-0002-0691-356X
Carroll, Martin
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08 CA230190, P30 CA016056, R50 CA211108, R25 CA181003, R21 CA198621)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (T32 HL007439)
American Society of Hematology (RTAF)
Leukemia and Lymphoma Society (Special Fellow Award)
Roswell Park Alliance Foundation, Roswell Park Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Veterans Affairs (I01BX004662)
Article History
Received: 10 April 2023
Revised: 13 December 2023
Accepted: 19 December 2023
First Online: 5 January 2024
Competing interests
: PJS, MS, SSR, HMX, KB, BM, GBW, LP, KK, JP, MJN, BAG, and SS declare no relevant competing interests. RLB has received honoraria from Mission Bio and is a member of the Speakers Bureau for Mission Bio. RLL is on the supervisory board of Qiagen and is a scientific advisor to Imago, Mission Bio, Bakx, Zentalis, Ajax, Auron, Prelude, C4 Therapeutics, and Isoplexis. RLL received research support from Abbvie, constellation, Ajax, Zentalis, and Prelude. RLL has received research support from and consulted for Celgene and Roche and has consulted for Syndax, Incyte, Janssen, Astellas, Morphosys, and Novartis. RLL has received honoraria from Astra Zeneca and Novartis for invited lectures and from Gilead and Novartis for grant reviews. SEM received research funding from CellCentric. KMB has received research funding from Syndax Pharmaceuticals, Inc. MC is on the Scientific Advisory Board for Cartography Biosciences.